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Summary
 
The almost uniform failure in transplant patients of tolerance-inducing regimens that have been
found to be effective in rodents, has made it necessary to examine large animal models before
testing of new approaches clinically. Miniature swine have been shown to share many relevant
immunologic parameters with humans, and because of their reproducible genetics, have proved
extremely useful in providing such a large animal model. We have previously shown that in-
definite systemic tolerance to renal allografts in miniature swine is induced in 100% of cases
across a two-haplotype class I plus minor histocompatibility antigen disparity by a 12-d course
of Cyclosporine A (CyA), in contrast to irreversible rejection observed uniformly without CyA
treatment. In the present study, we have examined the role of the thymus during the induction
of tolerance by performing a complete thymectomy 21 d before renal transplantation. This anal-
ysis demonstrated a striking difference between thymectomized and nonthymectomized ani-
mals. Thymectomized swine developed acute cellular rejection characterized by a T cell (CD25
 
1
 
)
infiltrate, tubulitis, endothelialitis and glomerulitis, and anti–donor CTL reactivity in vitro.
Nonthymectomized and sham thymectomized animals had a mild T cell infiltrate with few
CD25
 
1
 
 cells and no anti–donor CTL response in vitro. These results indicate that the thymus
is required for rapid and stable induction of tolerance.
 
M
 
any methods by which transplantation tolerance can
be induced in rodents have failed when applied to
large animals or to patients (1–4), making testing in large
animals a necessary step before applying new techniques
clinically. Miniature swine provide the only large animal
model in which one can reproducibly study the effects of
selective matching within the MHC on parameters of
transplantation (5–7). We have therefore used MHC in-
bred and recombinant lines of miniature swine extensively
for preclinical studies of transplantation tolerance (8–12).
Previous studies from this laboratory have demonstrated
that tolerance to renal allografts in miniature swine occurs
spontaneously in about one-third of animals selectively
matched for class II antigens and mismatched for a single
class I MHC locus plus minor antigens (8, 13). The induc-
tion of spontaneous long-term tolerance was associated with
a transient antidonor class I humoral response which has
been shown to be almost entirely of the IgM class. Rejec-
tor animals developed antidonor class I IgG and promptly
rejected their allografts. The failure to switch from IgM to
IgG in spontaneous acceptors, suggested that the pathway
to tolerance involved a deficiency of T cell help. Studies in
miniature swine mismatched for two class I haplotypes
were consistent with this hypothesis. Such animals reject
renal allografts in 100% of cases without immunosuppres-
sion, but when T cell help was limited by the administra-
tion of a 12-d course of Cyclosporine A (CyA)
 
1
 
, 100% of
animals developed long-term tolerance (9). Subsequent
studies demonstrated that transplants of second renal al-
lografts, MHC-matched to the original donors, were ac-
cepted without further immunosuppression if grafted at the
time of the transplant nephrectomy (14). These results in-
dicate that long-term graft acceptance is associated with the
induction of systemic tolerance.
The role of the thymus has been shown to be critical for
systemic central tolerance to self antigens in which poten-
 
1
 
Abbreviations used in this paper:
 
 CD, cluster of differentiation; CML, cell-
mediated lysis; CyA, Cyclosporine A; GIC, graft-infiltrating cell; PAS,
periodic acid–Schiff; POD, postoperative day; PSL, percent specific lysis;
SLA, swine lymphocyte antigen.
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tially autoreactive T cells are deleted or anergized by expo-
sure to the appropriate self antigens presented by either
bone marrow–derived cells or thymic stromal cells (15–19).
Similar intrathymic mechanisms may also be important in
inducing donor-specific tolerance to alloantigens, and there
are recent reports of studies in which donor alloantigens di-
rectly injected into the thymus resulted in donor-specific
tolerance to the alloantigens in vivo or in vitro (20–23). To
determine if the thymus is involved in the induction of tol-
erance in our two haplotype class I–mismatched renal al-
lograft model, the effect of thymectomy 21 d before renal
transplantation was examined. The data from this study
demonstrate that the thymus is essential for rapid and stable
tolerance induction. However, one graft was accepted by a
thymectomized animal, indicating that allograft tolerance
may also be achieved by peripheral mechanisms.
 
Materials and Methods
 
Animals.
 
Transplant donors and recipients were selected from
our herd of partially inbred miniature swine at 5–7 mo of age.
The immunogenetic characteristics of this herd and of the intra-
MHC recombinant haplotypes available have been described pre-
viously (5–7). The haplotypes of miniature swine used in this study
are shown schematically in Fig. 1. Recombinant swine lympho-
cyte antigen (SLA)
 
gg
 
 (class I
 
c
 
/II
 
d
 
) animals were used as kidney do-
nors, and SLA
 
dd
 
 (class I
 
d
 
/II
 
d
 
) animals were used as recipients to
achieve a 2-haplotype class I mismatch. All recipients were tested
for cell-mediated lympholysis (CML) reactivity to SLA
 
gg
 
 targets
before kidney transplantation, and demonstrated significant cyto-
toxic activity (
 
.
 
20% percent-specific lysis [PSL]).
 
Surgery.
 
The surgical procedures used for kidney transplants
have been described in detail previously (24, 25). A semiperma-
nent indwelling Hickman silastic central venous catheter was
placed surgically into the external jugular vein. The catheter facil-
itated CyA administration and frequent blood sampling for moni-
toring of renal function, whole blood CyA levels, and in vitro as-
says. A complete thymectomy was carried out 21 d before kidney
transplantation in the thymectomized group. The pretracheal
muscles were retracted exposing the trachea from the cervico-
thoracic junction to the mandibular area, as well as the thymus.
The cervical portion of the thymus was then dissected and ex-
cised. To achieve a complete thymectomy, a partial sternotomy
was then performed, and the thoracic portion of the thymus was
exposed. In the chest, the thymus consisted of nonencapsulated
tissue adherent to the pericardium, the pleura, and the large ves-
sels, and therefore careful dissection of this portion of the thymus
was required to complete the thymectomy (Fig. 2). Removed
thymic tissue was examined histologically and showed active thy-
mopoiesis (data not shown). Sham thymectomy was performed in
an identical fashion to complete thymectomy; however, thymic
tissue was not removed.
 
Immunosuppression.
 
CyA (Sandimmune) was provided by
Novartis Pharmaceutical Corp., (Hanover, NJ) and was mixed and
administered as an intravenous suspension according to specifica-
tions of the manufacturer. CyA was given daily as a single infu-
sion at a dose of 10–13 mg/kg (adjusted to maintain a blood level
of 400–800 ng/ml) for 12 consecutive d, starting on the day of
kidney transplantation. Whole blood trough levels were deter-
mined by a monoclonal radioimmunoassay, and the results were
expressed in ng/ml.
 
Rejection Monitoring.
 
Rejection was monitored by plasma cre-
atinine and histological examination of biopsy tissue. The clinical
endpoints used in this study were (
 
a
 
) death or euthanasia from
terminal uremia, and (
 
b
 
) survival 
 
.
 
100 d after kidney transplanta-
tion with a stable plasma creatinine.
 
Histology.
 
Sequential wedge kidney biopsies were performed
on postoperative day (POD) 8, 11, 18, 30, 60, and 
 
.
 
100 through
a flank incision. Tissues were stained using hematoxylin and eosin
and periodic acid–Schiff (PAS), and coded slides were examined.
Rejection was scored according to standard pathologic criteria
(26). Frozen sections for immunoperoxidase staining of kidney
biopsies were analyzed using the avidin-biotin–horseradish-per-
oxidase complex technique (27). A murine anti–pig mAb (K231-
3B2) recognizing the low affinity chain (p55, 
 
a
 
 chain) of the pig
IL-2R was used to assess cluster of differentiation (CD) 25 ex-
pression (28). 4-
 
m
 
m sections were incubated with 1% normal
horse serum and avidin (100 
 
m
 
g/ml in PBS) to inhibit nonspecific
binding of horse IgG and endogenous biotin, respectively. After
20 min, the tissue was covered with optimally diluted primary
mAb (mouse anti–pig mAb) and incubated for 60 min at room
temperature. Sections were rinsed in PBS and incubated in a so-
lution of biotin (10 
 
m
 
g/ml in PBS) with 0.3% hydrogen peroxide
for 30 min to block endogenous peroxidase. The biotinylated
secondary Ab (horse anti–mouse IgG) was added and incubated
for 45 min. After a further PBS wash, sections were incubated in
an optimal dilution of avidin-biotin–peroxidase complex (Dako
Corp., Carpinteria, CA) for 60 min, rinsed in PBS, and visualized
by staining with 0.02% hydrogen peroxide containing 0.3 mg/ml
3,3
 
9
 
-diaminobenzidine in 0.05 M Tris buffer. Staining was
stopped by dipping the slides into distilled water. Sections were
then counterstained with Gill’s single strength hematoxylin. Con-
trols included omission of primary Ab, horse anti–mouse Ab, and
an irrelevant primary mAb (36.7.5, murine anti–mouse K
 
k
 
; refer-
ence 29).
 
Preparation of PBL.
 
For separation of PBLs, freshly heparin-
ized whole blood was diluted 
 
z
 
1:2 with HBSS (GIBCO BRL,
Figure 1. Schematic diagram of the origin of available homozygous
porcine MHC haplotypes. Partially inbred SLAaa, SLAcc, and SLAdd hap-
lotypes were derived from the original founder miniature swine. Recom-
bination events between the MHC class I and class II haplotypes have
been identified and maintained as homozygous, recombinant haplotypes
SLAff, SLAgg, SLAhh, SLAjj, and SLAkk. 
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Gaithersburg, MD) and the mononuclear cells were obtained by
gradient centrifugation using lymphocyte separation medium (Or-
ganon Teknika, Durham, NC). The mononuclear cells were
washed once with HBSS, and contaminating red cells were lysed
with ammonium chloride potassium buffer (B&B Research Labora-
tory, Fiskeville, RI). Cells were then washed with HBSS and re-
suspended in tissue culture medium. All cell suspensions were
kept at 4
 
8
 
C until used in cellular assays.
 
Preparation of Graft Infiltrating Cells.
 
Kidney biopsy specimens
(100–500 mg) were finely minced with a scalpel blade and then
dispersed with the tip of a syringe plunger in HBSS buffer. The
cell suspension was then filtered through nylon mesh, pelleted by
centrifugation, and resuspended in flow cytometry media (see be-
low).
 
Flow Cytometry.
 
Flow cytometry of PBL and graft infiltrating
cells (GICs) was performed using a Becton Dickinson FACScan
 
Ò
 
(San Jose, CA). Cells were stained using directly FITC-labeled or
biotinylated mAbs and two-color analysis, as previously described
(30). The T cell content of PBLs and GICs was evaluated with
mAbs 74-12-4 (IgG2b, anti–swine CD4), 76-2-11 (IgG2a, anti–
swine CD8), MSA4 (IgG2a, anti–swine CD2), and K231-3B2
(IgG2a, anti–swine CD25, 
 
a
 
 chain) (28, 31–33), which were the
same antibodies used for immunohistochemistry. For staining,
cells were resuspended in flow cytometry buffer (HBSS contain-
ing 0.1% BSA, and 0.1% NaN
 
3
 
) and incubated for 1 h at 4
 
8
 
C
with saturating concentrations of a FITC-labeled mAb and a bi-
otinylated second mAb. After two washes, phycoerythrin-strepta-
 
vidin was added and incubated for 10 min. Cells were then
washed and analyzed using propidium iodide gating to exclude
dead cells.
 
CML Assay.
 
Tissue culture media used for CML assays con-
sisted of RPMI 1640 (GIBCO BRL) supplemented with 6% FCS
(Sigma Chemical Co., St. Louis, MO), 100 U/ml penicillin, and
135 
 
m
 
g/ml streptomycin (GIBCO BRL), 50 
 
m
 
g/ml gentamicin
(GIBCO BRL), 10 mM Hepes (Fisher Scientific, Pittsburgh, PA),
2 mM 
 
l
 
-glutamine (GIBCO BRL), 1 mM sodium pyruvate (Bio-
Whittaker, Inc., Walkersville, MD), nonessential amino acids
(BioWhittaker, Inc.) and 5 
 
3
 
 10
 
2
 
5
 
 M 
 
b
 
2 mercaptoethanol
(Sigma Chemical Co.). The effector phase of the CML assay was
performed using Basal Medium Eagle (GIBCO BRL) supple-
mented with 6% controlled processed serum replacement 3 CPSR-3
(Sigma Chemical Co.), and 10 mM Hepes (Fisher Scientific).
CML assays were performed as previously described (24, 25).
In brief, lymphocyte cultures containing 4 
 
3
 
 10
 
6
 
 responder and
4 
 
3
 
 10
 
6
 
 stimulator PBLs (irradiated with 2,500 rads) were incu-
bated for 6 d at 37
 
8
 
C in 7.5% CO
 
2
 
 and 100% humidity. Bulk cul-
tures were harvested and effectors tested for cytotoxic activity on
 
51
 
Cr (Amersham Corp., Arlington Heights, IL)-labeled targets
generated from lymphocytes stimulated for 24 h with a 1:500 di-
lution of phytohemagglutinin (M-Form; GIBCO BRL) previ-
ously titrated to give optimal proliferation. Effector cells were in-
cubated for 5.5 h with a negative control target (i.e., target PBL
matched to the effectors) and targets matched to the stimulators
which included donor-matched PBL (SLA
 
gg
 
: class I
 
cc
 
, class II
 
dd
 
)
and third party stimulators (SLA
 
aa
 
: class I
 
aa
 
, class II
 
aa
 
). E/T ratios of
100:1, 50:1, 25:1, and 12.5:1 were tested. Supernatants were har-
vested using the Skatron collection system (Skatron, Sterling, VA)
and 
 
51
 
Cr release was determined on a gamma counter (Micro-
medics, Huntsville, AL). The results were expressed as PSL, cal-
culated as:
PSL 
 
5
 
 [experimental release (cpm) 
 
2
 
 spontaneous release (cpm)/
maximum release (cpm) 
 
2
 
 spontaneous release (cpm)] 
 
3
 
 100.
 
Statistical Analysis.
 
Statistical analyses were performed by us-
ing the Student’s 
 
t
 
 test. A 
 
P 
 
value of 
 
,
 
0.05 was considered signif-
icant.
 
Results
 
Effect of Thymectomy on the Clinical Course of CyA-treated
Recipients of Class I–mismatched Kidney Transplants.
 
We have
previously reported that SLA
 
dd
 
 swine receiving SLA
 
gg
 
 kid-
ney transplants and a 12-d course of CyA uniformly ac-
cepted renal allografts (9). In the present study, we repro-
duced these results in four additional SLA
 
dd
 
 animals (No.
11468, 11561, 11574, and 10349). Two animals (No.
11561 and 11574) were removed from this experiment on
POD 42, since they were thymectomized at that time to
examine the possible effect of posttransplant thymectomy
on the maintenance of tolerance (to be reported elsewhere).
Two control animals (No. 10418 and 12019) underwent
sham thymectomy 21 d before transplantation to assess the
effect of this procedure on renal function. All nonthymecto-
mized animals, including the sham-thymectomized control
animals, had minimal renal dysfunction and subsequent sta-
ble renal function after cessation of CyA (Fig. 3 
 
b
 
). The five
thymectomized animals demonstrated a markedly different
clinical course (Fig. 3 
 
a
 
). Four animals (No. 10770, 10549,
Figure 2. Macroscopic findings of a completely resected thymus from a
thymectomized animal. 
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11573, and 11809) developed severe renal dysfunction.
Two of these animals (No. 10770 and 10549) died from
uremia on POD 26 (creatinine 4.8 mg/dl), and POD 51
(creatinine 7.8 mg/dl) respectively. One animal (No. 11573)
demonstrated a marked rise in creatinine for 3 wk after ces-
sation of CyA, and then died from cachexia on POD 42,
probably related to the massive proteinuria caused by trans-
plant glomerulopathy. The fourth animal (No. 11809) also
demonstrated severe renal dysfunction caused by an initial
acute rejection crisis. Its creatinine then stabilized at an ele-
vated value for several weeks, but the renal allograft was
lost eventually to chronic rejection. The last thymectomized
animal (No. 11301) developed a mildly elevated plasma
creatinine (peak 2.6 mg/dl) for a prolonged period, which
was a pattern not observed in the nonthymectomized ani-
mals, but which, nevertheless, led to long-term acceptance
(
 
.
 
100 d). The mean peak creatinine level of thymecto-
mized versus nonthymectomized animals was significantly
different (6.5 
 
6
 
 2.5 mg/dl versus 2.3 
 
6
 
 0.6 mg/dl, respec-
tively, 
 
P 
 
,
 
0.02). At autopsy, thymectomized animals were
examined for residual thymic tissue and, despite an exten-
sive dissection of the neck and upper mediastinum, no
macroscopic thymic tissue was detected in any of the five
animals. Histological analysis of multiple biopsy samples
taken at autopsy confirmed the absence of thymus.
 
Histological Analysis.
 
Serial kidney biopsies were per-
formed on POD 8, 11, 18, 30, 60, and 
 
.
 
100. Marked dif-
ferences in histology were noted between thymectomized
and nonthymectomized animals. Nonthymectomized animals
and the sham-thymectomized controls demonstrated a patchy
and mild mononuclear cell infiltrate with focal tubulitis be-
tween POD 8 and 18. Attachment of a few mononuclear
cells to the endothelium in small arteries and glomerular
capillaries was also observed (Fig. 4 
 
b
 
). The mononuclear
Figure 3. Clinical course of thymectomized animals (a) and nonthymectomized animals (b). D, died; S, killed due to progressive uremia; *, No. 11561,
11574. These pigs were excluded from this study on POD 42 (see text).
 
Figure 4.
 
Representative histological findings of thymectomized animals and nonthymectomized animals. (
 
a
 
) A thymectomized animal on POD 8; dif-
fuse and moderate mononuclear cell infiltration is seen with diffuse tubulitis. Glomeruli show typical acute allograft glomerulopathy (PAS 
 
3
 
200). (
 
b
 
) A
nonthymectomized animal on POD 8; mild and focal mononuclear cell infiltration is seen with mild focal tubulitis (PAS 
 
3
 
200). (
 
c
 
) Immunohistochem-
istry for CD25 on POD 8 in a thymectomized animal, and (d) a nonthymectomized animal. Many infiltrating mononuclear cells are seen expressing
CD25 in the thymectomized animal (c), whereas only a few of these cells are seen in nonthymectomized animal (d) (3600). (e) Thymectomized animal
on POD 60 shows chronic transplant glomerulopathy with diffuse interstitial fibrosis (PAS 3200), and (f) nonthymectomized animal show a normal
glomerular structure on POD 60 (PAS 3200).501 Yamada et al.502 Role of the Thymus in the Induction of Tolerance to Renal Allografts
cell infiltrate decreased by POD30, and remained minimal
(,5% of the cortex) throughout the remainder of the ex-
periment. In contrast, thymectomized animals showed
acute cellular rejection, with a diffuse and marked mono-
nuclear cell infiltration, tubulitis, and endothelialitis starting
on POD 8 (Fig. 4 a). The glomeruli also showed a mono-
nuclear cell infiltrate. By immunoperoxidase staining, both
groups showed an infiltrate of CD4 and CD8 cells. How-
ever, many infiltrating cells expressed CD25 in the thy-
mectomized animals (Fig. 4 c), whereas only a few infiltrating
cells expressed CD25 in nonthymectomized animals, indi-
cating more activation of infiltrating cells in thymecto-
mized animals (Fig. 4 d). In late biopsies, the thymecto-
mized animals developed chronic rejection, as manifested
by allograft glomerulopathy, consisting of the duplication
of glomerular basement membrane, marked mesangial pro-
liferation, and segmental mesangial sclerosis, observed on
POD 60 and 94 (Fig. 4 e). In addition, interstitial fibrosis
and tubular atrophy were present. The glomerular changes
correlated with proteinuria and weight loss in the thymec-
tomized animals, and were not seen in nonthymectomized
animals or the sham-thymectomized controls (Fig. 4 f).
Flow Cytometry. To assess the number of activated T
cells in the graft and PBLs semiquantitatively, GICs and
PBLs were examined by flow cytometry with the anti-
CD25 mAb. Fig. 5 shows CD25 expression on GICs on
POD8 in representative thymectomized and nonthymecto-
mized animals. CD25 was expressed on 36.6% of CD2-
positive GICs in the thymectomized animal, whereas only
1.4% of CD2-positive GICs expressed CD25 in the non-
thymectomized animal (Fig. 5, a and b). These results were
consistent with the immunohistological findings (Fig. 4, c
and d). CD25 expression in the GICs of thymectomized
animals decreased over time (data not shown). Representa-
tive CD8 versus CD4 staining of GICs from a thymecto-
mized animal (Fig. 5 c) and a nonthymectomized animal
(Fig. 5 d) demonstrated that the majority of the GICs were
CD8 single positive or CD4/8 double positive cells, with
very few CD4 single positive cells. Two-color flow cyto-
metric analysis indicated that the CD25-positive cells in the
thymectomized animals were observed in both the CD8-
positive and CD4-positive cells, which would correspond
mainly to the CD8 single positive and CD4/8 double posi-
tive cells since the CD4 single positive cell population
comprised  ,2% of the GICs. In addition, for both thymec-
tomized and nonthymectomized animals, most of GICs
were likely to be T cells since .80% of GICs were CD2-
positive cells (data not shown) and .80% of GICs were
also CD4 and/or CD8-positive cells (Fig. 5, c and d). No
major differences were observed in the expression of CD25
in the PBLs when comparing thymectomized and non-
thymectomized animals (data not shown).
CML. No significant difference in maximum antido-
nor cell PSL was demonstrated between the nonthymec-
tomized and thymectomized groups before kidney trans-
plantation (37.4 6 8.5%, thymectomized animals versus
34.1 6 7.6%, nonthymectomized animals, P .0.5). Post-
transplantation, thymectomized animals developed strong
antidonor cell reactivity, in contrast to nonthymectomized
animals and the sham-thymectomized animals which devel-
oped specific unresponsiveness to the donor class I antigens.
The difference in PSL was significant (thymectomized ani-
mals, 29.5 6 10.6% versus 3.5 6 3.8% nonthymectomized
controls, on POD 30, P ,0.004). Third-party reactivity
was maintained in both groups of animals (data not shown).
Fig. 6 shows CML reactivities of animals in both groups
against donor-matched target cells, at an E/T ratio of 100:1,
on POD 30.
Discussion
Miniature swine have been developed in this laboratory
over the past 20 yr as a large animal model for studies of
transplantation. Availability of animals inbred for SLA loci,
as well as of intra-MHC recombinant animals, make these
miniature swine the only large animal model in which one
can reproducibly study the effect of selective matching for
MHC class I or II loci. They also share many immunologic
Figure 5. Phenotype of GIC from typical thymectomized and non-
thymectomized animals. Flow cytometric analysis of the CD25 expression
(closed histogram) on GIC on POD 8 prepared from renal biopsies taken
from thymectomized (a) and nonthymectomized (b) animals is repre-
sented. The negative control antibody staining is also shown (open histo-
gram). The CD8 versus CD4 dot-plot analysis of the GIC on POD 8 is
shown for a thymectomized (c) and nonthymectomized animal (d). The
analysis of the phenotype shows the large number of CD8 single positive
and CD4/8 double positive GIC in both animals.503 Yamada et al.
and physiologic properties with humans, making them ex-
tremely useful as a preclinical model for transplantation. Of
particular relevance to the present studies is the fact that
most large animals, including human beings and swine, ex-
press class II antigens constitutively on the vascular endo-
thelium of their organs (34, 35), whereas rodents do not
(36, 37). We have postulated that this difference may be
relevant to the apparent unimportance of class II matching
to the outcome of vascularized transplants in rodents (38–
42), which stands in sharp contrast to the overwhelming
importance of class II matching to the outcome of such
transplants in humans (43) and in swine (8). Consistent with
this hypothesis, we have previously demonstrated that at least
one of the means by which tolerance to vascularized organ
allografts has been induced in rodents, i.e., by a short
course of CyA, is also uniformly efficacious in swine, but
only if one uses pairs of animals matched for class II anti-
gens (9).
Previous studies in this model have suggested that rejec-
tion and tolerance induction involve related but distinct
immunologic processes, which may be occurring simulta-
neously during the response to the allograft. Obviously, for
tolerance to be achieved, one must avoid rejection during
the critical period required for tolerance induction after the
transplant. Presumably, this prevention of rejection is ef-
fected by 12 d of CyA administration in this model. The
data presented here confirm the requirement for additional
immunologic events related to tolerance induction to oc-
cur during this period, since the immune response to the
allograft after CyA was discontinued was affected markedly
by the absence of a thymus. The nature of the immuno-
logic events for which the thymus is required to induce tol-
erance in this system remain unclear.
Two categories of explanations seem plausible. (a) Cells
(possibly dendritic cells) from the kidney graft may migrate
to the thymus and may be responsible for a central compo-
nent in both the induction and maintenance of tolerance in
this system. A variation of this explanation would involve
host cells picking up antigen in the graft and migrating to
the thymus, with a similar effect. A recent study from our
laboratory has used a sensitive PCR assay that was able to
distinguish the host class I allele (SLAd) from the donor class
I allele (SLAc) (Consorti, R., K. Yamada, S. Germana, D.H.
Sachs, and C. Le Guern, manuscript in preparation). Al-
though this assay was able to detect chimerism in skin and
lymph node of some animals in a different protocol, no chi-
merism was observed in the thymus of swine that received a
class I disparate renal allograft with CyA and were thymec-
tomized on POD 8 or 42. This finding supports the hy-
pothesis that if antigen presentation in the thymus is involved,
donor class I peptides, rather than donor cells, may be the
source of such antigen. Since hosts and donors are class II
matched in these studies, processed class I antigens presented
by class II antigens in the thymus would be expected to be
identical regardless of whether the migrating cell were from
donor or host. Thus, tolerance at the level of CD4 helper
cells recognizing class I peptides through the indirect path-
way, might be expected in both cases. The main difference
between migration of donor cells versus host cells bearing
donor antigens would involve tolerization of the direct
pathway, which would only be possible if intact class I anti-
gen, such as that expressed on donor cells, were involved in
the intrathymic deletion. Since we have evidence for per-
sistence of anti–class I CTLp in tolerant animals (44), toler-
ance at the level of helper cells may be sufficient to explain
the intrathymic component of tolerance induction.
(b) Thymic emigrants may be responsible for permitting
tolerance induction peripherally for alloreactive cells in the
graft. Such peripheral tolerance could be mediated by a
change in cytokine milieu or by regulatory responses in-
cluding suppressive mechanisms. Recent studies have dem-
onstrated that autoreactive T cells associated with synge-
neic graft versus host disease induced by CyA may facilitate
acceptance of MHC disparate cardiac allografts by the elim-
ination of alloreactive lymphocytes (45). It was postulated
that the T cells responsible for the prolongation of graft
survival arose through inhibition of intrathymic clonal de-
letion of MHC class II autoreactive T cells. Suppressor mech-
anisms have also been reported in rodent models, in which
one group identified a CD4-positive cell as the regulatory
cell population (46–51). Additional studies have indicated
that CD4-positive cells are capable of downregulating spe-
cific immune responses by local secretion of cytokines such
as IL-10 and IL-4, and selective activation of such cells may
occur (52–54). The apparent suppression may be explained
by changes of cytokine milieu, which could result from a
thymic-dependent distribution of helper cell types periph-
erally. Thus, Th1 cells produce IL-2 and IFN-g, whereas
the Th2 cells secrete IL-4 and IL-10. Regulatory pathways
are likely to exist since in vitro IL-4 and IL-10 suppress
IFN-g production by Th1 cells, and Th2 cytokine produc-
tion can be inhibited by IFN-g. It is likely that alteration in
cytokine production plays an important role in the induc-
tion of tolerance in our class I mismatch renal allograft
Figure 6. CTL antidonor reactivity on POD 30 in thymectomized an-
imals and nonthymectomized animals. PSL at an E/T ratio of 100:1 was
significantly higher in thymectomized animals when compared to non-
thymectomized animals.504 Role of the Thymus in the Induction of Tolerance to Renal Allografts
model since inhibition of T cell help (IL-2) by CyA leads
to long-term tolerance (9), and furthermore, altered cyto-
kine production consistent with differential activation of
Th1 and Th2 cells has been demonstrated in renal tissue
from allografts (55, 56). The latter studies demonstrate that
renal biopsies from tolerant animals show high levels of IL-10
and low levels of IFN-g gene transcription, whereas reject-
ing animals show a marked upregulation of IFN-g gene
transcription. Additional studies of renal tissue from thy-
mectomized animals demonstrated that these animals ex-
press high levels of IFN-g during a rejection crisis (Blancho,
G., K. Yamada, F.L. Ierino, P.R. Gianello, I. McMorrow,
S. Germana, A. Shimizu, R.B. Colvin, C. LeGuern, and
D.H. Sachs, manuscript in preparation). However, it re-
mains to be determined if this dysregulated cytokine pro-
duction is a cause or effect of the induction and mainte-
nance of tolerance in this swine model.
One animal in this study became tolerant without a thy-
mus, albeit with a less stable clinical course, and this phe-
nomenon has been confirmed in additional animals as part
of ongoing studies on the timing of thymectomy (to be
presented elsewhere). Such results imply that both central
and peripheral mechanisms for induction of tolerance must
exist. It seems likely that nonthymectomized animals use
both peripheral and central mechanisms of tolerance, which
would explain tolerance to the numerous minor antigens
that would most likely escape thymic mechanisms. These
peripheral mechanisms may include anergy and/or suppres-
sion. As noted above, peripheral mechanisms regulating al-
loresponses are influenced by cells arising from the thymus
so that peripheral and central mechanisms may be interde-
pendent. Additional studies in this model will investigate
the effects on tolerance induction of the timing of thymec-
tomy and of other manipulations known to affect the thy-
mus such as administration of steroids, thymic biopsy, and
the aging process.
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